Alexander O. Schuth - Aug 9, 2022 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
COFO and Secretary
Signature
/s/ Tyler Nielsen, by power of attorney
Stock symbol
DNLI
Transactions as of
Aug 9, 2022
Transactions value $
$0
Form type
4
Date filed
8/11/2022, 07:21 PM
Previous filing
Feb 15, 2022
Next filing
Aug 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Award $0 +22.5K +22.74% $0.00 121K Aug 9, 2022 Direct F1, F2, F3
holding DNLI Common Stock 465K Aug 9, 2022 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on August 9, 2023 (the"Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a serviceprovider of the Issuer through each such date.
F2 Includes 109,822 restricted stock units.
F3 Includes 540 shares acquired under the ESPP Purchase on May 31, 2022.
F4 The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.